Parmax Pharma Limited held an Extra Ordinary General Meeting (EGM) of its members on Wednesday, May 27, 2026, at 02:30 P.M. at the company's registered office. The meeting commenced at 02:30 P.M. and concluded at 03:00 P.M.

Attendance and Proceedings

Total 15 members attended the EGM. The meeting was also attended by representatives of the Secretarial Auditor of the Company and the Scrutinizer for the EGM - M/s. Samsad Alam Khan. Mr. Umang Gosalia, Managing Director of the Company, presided as Chairman of the EGM.

The Chairman confirmed that requisite quorum was present and called the meeting in order. He informed that notice of the EGM had been circulated by electronic means to all members whose email IDs were registered with the depositories. The notice was also uploaded on the website of the Company, BSE, and Purva Sharegistry India Private Limited (E-Voting Service Provider).

Voting Arrangements

The company provided remote e-voting facility through Purva Sharegistry India Private Limited, which was kept open from 9:00 A.M. (IST) on Sunday, May 24, 2026, until 5:00 P.M. (IST) on Tuesday, May 26, 2026. Additionally, voting facility through ballot paper was provided during the EGM for members who had not voted through remote e-voting and were present at the meeting.

Resolutions Considered and Approved

The following five resolutions were considered and approved by the members:

1. Ordinary Resolution: Appointment of Mr. Pradeep Ramniklal Gosalia (DIN: 01130646) as a Non-Executive Director of the Company

2. Ordinary Resolution: Appointment of Ms. Salma Badrudin Thobhani (DIN: 11616267) as Non-Executive Director of the Company

3. Special Resolution: Appointment of Mr. Ashish Atmaram Shah (DIN: 06873593) as a Non-Executive and Independent Director of the Company

4. Special Resolution: Appointment of Ms. Anjana Paresh Shah (DIN: 00845784) as a Non-Executive and Independent Director of the Company

5. Special Resolution: Re-appointment of Mr. Umang Alkesh Gosalia (DIN: 05153830) as Managing Director

Disclosure and Compliance

The disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results of the voting together with the report of the scrutinizer will be disclosed to the Stock Exchange and displayed on the company's website.

Financial Impact

No specific financial impact quantified in the disclosure.